Medtronic and Schwarzer Cardiotek announce distribution agreement
Hemodynamic measurement stations update Munich Municipal Hospitals
evolution - hemodynamics 2018
Extended Medtronic EMEA co-marketing cooperation
Toshiba Medical Systems - European distribution agreement
Schwarzer Cardiotek introduces software version 2.2 for the electrophysiological measuring system EP-TRACER.
Schwarzer Cardiotek receives FDA 510(k) clearance for software version 2
EP-TRACER - The Film
New User Reports about EP-TRACER Portable
Schwarzer Cardiotek presents software version 2 of its electrophysiogical measuring system EP-TRACER
Schwarzer Cardiotek concludes filling of key management-level positions
Philips und Schwarzer Cardiotek conclude reseller agreement for the cardiology information system cardWorks
Schwarzer GmbH, Heilbronn Germany, And Cardiotek B.V., Maastricht, The Netherlands Announces That The Two Companies Will Merge Under The New Brand Of Schwarzer Cardiotek
NICE, France, June 18, 2014 /PRNewswire/ -- Schwarzer Cardiotek today announced that it has completed the integration of the two companies. For the first time the company will showcase the combined portfolio of the merged entity and will be introducing its new corporate identity at CARDIOSTIM.
"Both Schwarzer and Cardiotek have always utilized a comprehensive approach of creative thinking and expert collaboration to develop breakthrough innovations that improve clinician workflows. We are excited to launch one strong brand that reflects our core values and desire to provide the highest level of innovation to our customers," stated Frank-P. Klein, President and Chief Commercial Officer of Schwarzer.
Given its strong loyalty in the electrophysiology market, the EP-Tracer system will be highlighted at CARDIOSTIM. "Throughout the majority of my career and for thousands of ablations, I have used the EP-Tracer system as my primary EP recording system. The system offers superior signal quality in a compact, single-user system," commented Dr. Josep Brugada M.D. Ph.D., Electrophysiologist and Medical Director at the University of Hospital Clinic Barcelona in Spain.
The integration of the two companies creates synergies and new product offerings. An example is the evoduo system. By combining Cardiotek's EP-Tracer system with Schwarzer's evo system the integrated company is leveraging its innovative and proven technologies to create a powerful offering in the evoduo product. "The evoduo system is an important product for Schwarzer Cardiotek. It realizes the technology integration of Schwarzer's hemodynamic expertise with Cardiotek's competency in EP recorder and stimulator systems," continued Frank-P. Klein.
Schwarzer Cardiotek's new corporate brand identity and the EP-Tracer product line will be on display at booth A29 at the CARDIOSTIM meeting.
Cardiotek Announces U.S. Commercialization of the EP-Tracer System Company to Showcase the System at 2014 HRS Meeting